ORMP · Oramed Pharmaceuticals Inc.
$3.97
-0.20 (-4.80%)
At close · Jul 29
Market Cap
$170.66M
Shares
40.93M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$469,000
as of 2026-03-31
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $4,741,000 | 10-K, filed 2026-03-26 |
| 2024-12-31 | $2,484,000 | 10-K, filed 2026-03-26 |
Key facts
CIK
1176309
CUSIP
68403P203
13F (30d)
11 filings
11 filers
Visit website
Investor relations